Enhancement of osseointegration by direct coating of rhBMP-2 on target-ion induced plasma sputtering treated SLA surface for dental application

Owing to the excellent bioactive properties of recombinant human bone morphogenetic proteins (rhBMPs), dentistry considers them as a fascinating adjuvant alternative for enhancing bone regeneration and bone-to-implant junction in the early implantation stages. However, stable loading and delivery efficiency of rhBMPs on the implant surfaces involve major concerns because of the harsh wearing condition under load during implantation. In this study, to achieve successful rhBMP-2 delivery, a nanoporous surface structure is introduced on the sandblasting with large grit and acid-etching (SLA)-treated titanium (Ti) surface via the tantalum (Ta) target-ion induced plasma sputtering (TIPS) technique. Unlike oxidation-induced surface nanoporous fabrications on a Ti surface, TIPS-treated surfaces provide excellent structural unity of the nanoporous structure with the substrate due to their etching-based fabrication mechanism. SLA/TIPS-treated Ti exhibits distinct nanoporous structures on the microscale surface geometry and better hydrophilicity compared with SLA-treated Ti. A sufficiently empty nanoporous surface structure combined with the hydrophilic property of SLA/TIPS-treated Ti facilitates the formation of a thick and uniform coating layer of rhBMP-2 on the surface without any macro- and microcoagulation. Compared with the SLA-treated Ti surface, the amount of coated rhBMP-2 increases up to 63% on the SLA/TIPS-treated Ti surface. As a result, the in vitro pre-osteoblast cell response of the SLA/TIPS-treated Ti surface, especially cell adhesion and differentiation behaviors, improves remarkably. A bone-regenerating direct comparison between the rhBMP-2-coated SLA-treated and SLA/TIPS-treated Ti is conducted on a defective dog mandible model. After 8 weeks of implantation surgery, SLA/TIPS-treated Ti with rhBMP-2 exhibits a better degree of contact area for the implanted bone, which mineralizes new bones around the implant. Quantitative results of bone-in-contact ratio and new bone volume also show significantly higher values for the SLA/TIPS-treated Ti with the rhBMP-2 specimen. These results confirm that an SLA/TIPS-treated surface is a suitable rhBMP-2 carrier for a dental implant to achieve early and strong osseointegration of Ti dental implants.

[1]  Haw-Ming Huang,et al.  Fibronectin-Grafted Titanium Dental Implants: An In Vivo Study , 2016, BioMed research international.

[2]  Hyoun‐Ee Kim,et al.  Large-scale nanopatterning of metal surfaces by target-ion induced plasma sputtering (TIPS) , 2016 .

[3]  Wen‐Cheng Chen,et al.  Effects of Osseointegration by Bone Morphogenetic Protein-2 on Titanium Implants In Vitro and In Vivo , 2016, Bioinorganic chemistry and applications.

[4]  J. Ryu,et al.  Effects of rhBMP-2 on Sandblasted and Acid Etched Titanium Implant Surfaces on Bone Regeneration and Osseointegration: Spilt-Mouth Designed Pilot Study , 2015, BioMed research international.

[5]  A. Barfeie,et al.  Implant surface characteristics and their effect on osseointegration , 2015, BDJ.

[6]  Changyou Gao,et al.  Role of adsorbed proteins on hydroxyapatite-coated titanium in osteoblast adhesion and osteogenic differentiation , 2015 .

[7]  Hyoun‐Ee Kim,et al.  Creation of hierarchical micro/nano-porous TiO2 surface layer onto Ti implants for improved biocompatibility , 2014 .

[8]  Lu Han,et al.  BMP2-encapsulated chitosan coatings on functionalized Ti surfaces and their performance in vitro and in vivo. , 2014, Materials science & engineering. C, Materials for biological applications.

[9]  Limin Wei,et al.  BMP-Functionalised Coatings to Promote Osteogenesis for Orthopaedic Implants , 2014, International journal of molecular sciences.

[10]  L. Kovačević,et al.  Influence of substrate roughness on adhesion of TiN coatings , 2014 .

[11]  S. Peel,et al.  Bone response to the multilayer BMP-2 gene coated porous titanium implant surface. , 2013, Clinical oral implants research.

[12]  M. Muthukuru.  Bone morphogenic protein-2 induces apoptosis and cytotoxicity in periodontal ligament cells. , 2013, Journal of periodontology.

[13]  Sang‐Wan Shin,et al.  The effect of anodized implants coated with combined rhBMP-2 and recombinant human vascular endothelial growth factors on vertical bone regeneration in the marginal portion of the peri-implant. , 2013, Oral surgery, oral medicine, oral pathology and oral radiology.

[14]  J. Ryu,et al.  Physical stability of arginine-glycine-aspartic acid peptide coated on anodized implants after installation , 2013, The journal of advanced prosthodontics.

[15]  H. Lai,et al.  The roles of PI3K/Akt signaling pathway in regulating MC3T3-E1 preosteoblast proliferation and differentiation on SLA and SLActive titanium surfaces. , 2013, Journal of biomedical materials research. Part A.

[16]  Hyoun‐Ee Kim,et al.  Bone morphogenic protein-2 (BMP-2) loaded hybrid coating on porous hydroxyapatite scaffolds for bone tissue engineering , 2013, Journal of Materials Science: Materials in Medicine.

[17]  S. Kang,et al.  Effects of anodized implants coated with Escherichia coli-derived rhBMP-2 in beagle dogs. , 2012, International journal of oral and maxillofacial surgery.

[18]  Hyoun‐Ee Kim,et al.  Creation of nanoporous tantalum (Ta)-incorporated titanium (Ti) surface onto Ti implants by sputtering of Ta in Ar under extremely high negative substrate biases , 2012 .

[19]  Byung-Soo Kim,et al.  Comparison between heparin-conjugated fibrin and collagen sponge as bone morphogenetic protein-2 carriers for bone regeneration , 2012, Experimental & Molecular Medicine.

[20]  Sang‐Wan Shin,et al.  Alveolar ridge augmentation using anodized implants coated with Escherichia coli-derived recombinant human bone morphogenetic protein 2. , 2011, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[21]  Pierre Layrolle,et al.  Nanotechnology and Dental Implants , 2010, International journal of biomaterials.

[22]  Y. Yang,et al.  Anodic oxidized nanotubular titanium implants enhance bone morphogenetic protein-2 delivery. , 2010, Journal of biomedical materials research. Part B, Applied biomaterials.

[23]  Y. Yang,et al.  Fabrication and characterization of functionally graded nano-micro porous titanium surface by anodizing. , 2009, Journal of biomedical materials research. Part B, Applied biomaterials.

[24]  In-Seop Lee,et al.  The biocompatibility of SLA-treated titanium implants , 2008, Biomedical materials.

[25]  Helge Toutenburg,et al.  Enhanced implant stability with a chemically modified SLA surface: a randomized pilot study. , 2007, The International journal of oral & maxillofacial implants.

[26]  P. Layrolle,et al.  Surface treatments of titanium dental implants for rapid osseointegration. , 2007, Dental materials : official publication of the Academy of Dental Materials.

[27]  E. Hunziker,et al.  The influence of BMP-2 and its mode of delivery on the osteoconductivity of implant surfaces during the early phase of osseointegration. , 2007, Biomaterials.

[28]  D. J. Varacalle,et al.  Effect of grit-blasting on substrate roughness and coating adhesion , 2006 .

[29]  L. Scheideler,et al.  Enhancing surface free energy and hydrophilicity through chemical modification of microstructured titanium implant surfaces. , 2006, Journal of biomedical materials research. Part A.

[30]  Andreas Sewing,et al.  Effect of immobilized bone morphogenic protein 2 coating of titanium implants on peri-implant bone formation. , 2005, Clinical oral implants research.

[31]  Kozo Nakamura,et al.  Bone Morphogenetic Protein 2-Induced Osteoblast Differentiation Requires Smad-Mediated Down-Regulation of Cdk6 , 2004, Molecular and Cellular Biology.

[32]  A. Diaspro,et al.  Dynamics of green fluorescent protein mutant2 in solution, on spin‐coated glasses, and encapsulated in wet silica gels , 2002, Protein science : a publication of the Protein Society.

[33]  Jean-Pierre Bernard,et al.  The use of reduced healing times on ITI implants with a sandblasted and acid-etched (SLA) surface: early results from clinical trials on ITI SLA implants. , 2002, Clinical oral implants research.

[34]  C. Watson,et al.  A comparison of hydroxylapatite coated implant retained fixed and removable mandibular prostheses over 4 to 6 years. , 2001, Clinical Oral Implants Research.

[35]  R. Tuan,et al.  Mechanism of BMP‐2 stimulated adhesion of osteoblastic cells to titanium alloy , 1999, Biology of the cell.

[36]  H. Rack,et al.  Titanium alloys in total joint replacement--a materials science perspective. , 1998, Biomaterials.

[37]  B. Kasemo,et al.  Bone response to surface-modified titanium implants: studies on the early tissue response to machined and electropolished implants with different oxide thicknesses. , 1996, Biomaterials.

[38]  S. Hwang,et al.  Analysis of attachment, proliferation and differentiation response of human mesenchymal stem cell to various implant surfaces coated with rhBMP-2 , 2012 .

[39]  L. Filgueira,et al.  Apoptosis induction and reduced proliferation in human osteoblasts by rhBMP-2, -4 and -7. , 2009, Journal of musculoskeletal & neuronal interactions.

[40]  Ana Mellado-Valero,et al.  Effects of diabetes on the osseointegration of dental implants. , 2007, Medicina oral, patologia oral y cirugia bucal.

[41]  藁科 秀紀.  Biological reaction to alumina, zirconia, titanium and polyethylene particles implanted onto murine calvaria , 2004 .

[42]  Urs C Belser,et al.  Early loading of nonsubmerged titanium implants with a sandblasted and acid-etched (SLA) surface: 3-year results of a prospective study in partially edentulous patients. , 2003, The International journal of oral & maxillofacial implants.

[43]  G. Wolfinger,et al.  Dental implants in the diabetic patient: a retrospective study. , 1999, Implant dentistry.

[44]  S. Wheeler.  Eight-year clinical retrospective study of titanium plasma-sprayed and hydroxyapatite-coated cylinder implants. , 1996, The International journal of oral & maxillofacial implants.

[45]  I Lundström,et al.  Physico-chemical considerations of titanium as a biomaterial. , 1992, Clinical materials.